307 related articles for article (PubMed ID: 26303418)
1. Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments.
Schnekenburger M; Florean C; Dicato M; Diederich M
Curr Top Med Chem; 2016; 16(7):745-76. PubMed ID: 26303418
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
3. Epigenome-based personalized medicine in human cancer.
Yan W; Herman JG; Guo M
Epigenomics; 2016 Jan; 8(1):119-33. PubMed ID: 26344672
[TBL] [Abstract][Full Text] [Related]
4. DNA demethylating agents and epigenetic therapy of cancer.
Mani S; Herceg Z
Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
6. Targeting Chromatin Remodeling for Cancer Therapy.
Kaur J; Daoud A; Eblen ST
Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
[TBL] [Abstract][Full Text] [Related]
7. Targeting the histone orthography of cancer: drugs for writers, erasers and readers.
Simó-Riudalbas L; Esteller M
Br J Pharmacol; 2015 Jun; 172(11):2716-32. PubMed ID: 25039449
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy.
Lu Y; Chan YT; Tan HY; Li S; Wang N; Feng Y
Mol Cancer; 2020 Apr; 19(1):79. PubMed ID: 32340605
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
10. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
11. Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation.
Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
Curr Pharm Des; 2017; 23(8):1167-1174. PubMed ID: 27774908
[TBL] [Abstract][Full Text] [Related]
12. Histone modification therapy of cancer.
Biancotto C; Frigè G; Minucci S
Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
[TBL] [Abstract][Full Text] [Related]
14. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
Valdespino-Gómez VM; Valdespino-Castillo VE
Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic-based therapies in cancer: progress to date.
Song SH; Han SW; Bang YJ
Drugs; 2011 Dec; 71(18):2391-403. PubMed ID: 22141383
[TBL] [Abstract][Full Text] [Related]
16. Chromatin-modifying agents in anti-cancer therapy.
Seidel C; Florean C; Schnekenburger M; Dicato M; Diederich M
Biochimie; 2012 Nov; 94(11):2264-79. PubMed ID: 22627380
[TBL] [Abstract][Full Text] [Related]
17. Review-Epigenetic therapy for cancer.
Saleem M; Abbas K; Manan M; Ijaz H; Ahmed B; Ali M; Hanif M; Farooqi AA; Qadir MI
Pak J Pharm Sci; 2015 May; 28(3):1023-32. PubMed ID: 26004710
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modifications as therapeutic targets.
Kelly TK; De Carvalho DD; Jones PA
Nat Biotechnol; 2010 Oct; 28(10):1069-78. PubMed ID: 20944599
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic drugs take on cancer.
Kaiser J
Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
[No Abstract] [Full Text] [Related]
20. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.
Biswas S; Rao CM
Eur J Pharmacol; 2018 Oct; 837():8-24. PubMed ID: 30125562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
